Methylprednisolone sodium succinate and Retinal detachment - a phase IV clinical study of FDA data

Summary:

Retinal detachment is reported as a side effect among people who take Methylprednisolone sodium succinate (methylprednisolone sodium succinate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Pantoprazole, and have Chronic graft versus host disease.

The phase IV clinical study analyzes which people have Retinal detachment when taking Methylprednisolone sodium succinate. It is created by eHealthMe based on reports of 18,153 people who have side effects when taking Methylprednisolone sodium succinate from the FDA, and is updated regularly.

What is Methylprednisolone sodium succinate?

Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 18,163 Methylprednisolone sodium succinate users. Check the latest studies of Methylprednisolone sodium succinate.

What is Retinal detachment?

Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue) is found to be associated with 714 drugs and 1,007 conditions by eHealthMe. Check the latest studies of Retinal detachment.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

18,153 people reported to have side effects when taking Methylprednisolone sodium succinate.
Among them, 25 people (0.14%) have Retinal detachment.

Could Methylprednisolone sodium succinate cause Retinal detachment?

Among these 25 people:

How long have people been on Methylprednisolone sodium succinate when they have Retinal detachment? *

What is the gender of people who have Retinal detachment when taking Methylprednisolone sodium succinate? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Retinal detachment when taking Methylprednisolone sodium succinate? *

What are other drugs people take besides Methylprednisolone sodium succinate? *

What are other side effects people have besides Retinal detachment? *

High Blood Pressure: 13 people, 52.00%
Blood Pressure Diastolic Abnormal: 12 people, 48.00%
Blood Pressure Fluctuation: 12 people, 48.00%
Oxygen Saturation Decreased: 12 people, 48.00%
Infusion Related Reaction: 11 people, 44.00%
Blood Pressure Systolic Increased: 10 people, 40.00%
Cataract (clouding of the lens inside the eye): 10 people, 40.00%
Weight Decreased: 8 people, 32.00%
Chorioretinopathy (collection of fluid under the retina that results in visual distortion): 7 people, 28.00%
Weight Increased: 6 people, 24.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 24.00%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 6 people, 24.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 16.00%
Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 3 people, 12.00%
Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 3 people, 12.00%
Vogt-Koyanagi-Harada Syndrome (disease of the eyes characterized by bilateral uveitis, alopecia, skin disease with depigmentation and hearing loss): 2 people, 8.00%
Prostate Cancer: 2 people, 8.00%
Immunodeficiency Disorders: 2 people, 8.00%
High Blood Pressure: 2 people, 8.00%
Depression: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone sodium succinate and have Retinal detachment?

- Check whether Retinal detachment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone sodium succinate:

Methylprednisolone sodium succinate (18,163 reports)

Retinal detachment treatments and more:

Retinal detachment (11,679 reports)

How severe was Retinal detachment and when was it recovered:

Retinal detachment in Methylprednisolone sodium succinate

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Retinal detachment and drugs with ingredients of methylprednisolone sodium succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone sodium succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal detachment:

Retinal detachment (714 drugs)

Browse all the conditions that are associated with Retinal detachment:

Retinal detachment (1,007 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Methylprednisolone sodium succinate) and Methylprednisolone sodium succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.